Log in

3407 Asahi Kasei Corporation TSE · Japan

Asahi Kasei (3407) news

Asahi Kasei Corporation is a public biotech or pharmaceutical company listed on TSE under the ticker 3407, recorded under Japan. The directory classifies it as Diversified pharmaceuticals. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Asahi Kasei news

We have not published a story on Asahi Kasei yet. When there is news, it will appear here.

Questions about Asahi Kasei

What is the ticker symbol of Asahi Kasei?

Asahi Kasei Corporation trades under the ticker 3407 on TSE.

Where is Asahi Kasei listed?

Asahi Kasei Corporation is listed on TSE.

Which country or territory is Asahi Kasei listed under?

Our directory records Asahi Kasei Corporation under Japan.

What does Asahi Kasei do?

Our directory classifies Asahi Kasei Corporation as: Diversified pharmaceuticals. This is a directory classification, not a description of the pipeline.

What is the ISIN of Asahi Kasei?

The ISIN recorded for Asahi Kasei Corporation is JP3111200006.

Does aibio.space cover Asahi Kasei?

aibio.space lists Asahi Kasei Corporation among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Asahi Kasei?

Companies in our directory listed in the same country and business area as Asahi Kasei: Kobayashi Pharmaceutical Co., Human Metabolome Technologies, Carna Biosciences, Symbio Pharmaceuticals, Kringle Pharma, Kyowa Kirin Co..

Investor discussion: Asahi Kasei

Members talk about Asahi Kasei (3407). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TSE:3407 on TradingView.

Listing details

Asahi Kasei Corporation is a public biotech or pharmaceutical company listed on TSE under the ticker 3407, recorded under Japan. The directory classifies it as Diversified pharmaceuticals. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Asahi Kasei Corporation
Ticker
3407
Listing
TSE
Country or territory
Japan
Business scope
Diversified pharmaceuticals
ISIN
JP3111200006
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.